PE Tech Report


Like this article?

Sign up to our free newsletter

Eckuity to invest in Mobius Biomedical

New York- and London-based HealthTech venture firm Eckuity has invested in Mobius Biomedical, a development-stage company designing disruptive new technology and processes for lower cost, next-generation biologics manufacturing.

Mobius Biomedical’s disruptive technology will significantly reduce facility footprint, setup time, and cost, while at the same time providing the flexibility to manufacture a diverse set of biological drug products, as its flexible equipment modules are designed to enable continuous manufacturing of protein-therapeutics, RNA-therapeutics, and gene therapies. Mobius’ technologies will provide reductions in manufacturing cost and time to market, while simultaneously improving product yield and purity.

Like this article? Sign up to our free newsletter